New insights into orthostatic hypotension in multiple system atrophy: A European multicentre cohort study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 5, 2016, Pages 554-561

  Pavy Le Traon, A ^a,b   Piedvache, A ^c   Perez Lloret, S ^a,d   Calandra Buonaura, G ^e,f   Cochen De Cock, V ^a,g   Colosimo, C ^h   Cortelli, P ^e,f   Debs, R ^a   Duerr, S ⁱ   Fanciulli, A ⁱ   Foubert Samier, A ^j,k   Gerdelat, A ^a   Gurevich, T ^l   Krismer, F ⁱ   Poewe, W ⁱ   Tison, F ^j,k   Tranchant, C ^m   Wenning, G ⁱ   Rascol, O ^a   Meissner, W G ^j,k  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Université de Toulouse   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^g UNIVERSITY OF MONTPELLIER   (France)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

^k UNIVERSITÉ DE BORDEAUX   (France)

^l TEL AVIV UNIVERSITY   (Israel)

^m HÔPITAL DE HAUTEPIERRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HYPERTENSIVE AGENT; LEVODOPA;

ADULT; ARTICLE; CEREBELLAR ATAXIA; COHORT ANALYSIS; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE ASSESSMENT; ORTHOSTATIC HYPOTENSION; ORTHOSTATIC INTOLERANCE; PARKINSONISM; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SUPINE HYPERTENSUION; UNIFIED MULTIPLE SYSTEM ATROPHY RATING SCALE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMORBIDITY; EUROPE; HYPOTENSION, ORTHOSTATIC; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SYSTEM ATROPHY;

BLOOD PRESSURE DETERMINATION; COHORT STUDIES; COMORBIDITY; EUROPE; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY;

EID: 84968724565     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309999     Document Type: Article

References (34)

1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-6.
2. O'Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008;131(Pt 5):1362-72.
3. No authors listed]. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996;46:1470.
4. Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 2006;114:630-64.
5. Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens 2011;24:135-44.
6. Jamnadas-Khoda J, Koshy S, Mathias CJ, et al. Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory. Mov Disord 2009;24:1747-51.
7. Wenning GK, Tison F, Seppi K, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004;19:1391-402.
8. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
9. Wenning GK, Geser F, Krismer F, et al; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013;12:264-74.
10. Arnold AC, Shibao C. Current concepts in orthostatic hypotension management. Curr Hypertens Rep 2013;15:304-12.
11. Braam EA, Verbakel D, Adiyaman A, et al. Orthostatic hypotension: revision of the definition is needed. J Hypertens 2009;27:2116-20.
12. Wieling W, Schatz IJ. The consensus statement on the definition of orthostatic hypotension: a revisit after 13years. J Hypertens 2009;27:935-93.
13. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011;21:69-72.
14. Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 2006;67:28-32.
15. Chang KV, Chen WS, Wu RM, et al. Pulsed wave Doppler ultrasound is useful to assess vasomotor response in patients with multiple system atrophy and well correlated with tilt table study. Sci World J 2012;2012:548529.
16. Arnold AC, Okamoto LE, Gamboa A, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 2013;61:701-6.
17. Gehrking JA, Hines SM, Benrud-Larson LM, et al. What is the minimum duration of head-up tilt necessary to detect orthostatic hypotension? Clin Auton Res 2005;15:71-5.
18. Benarroch EE. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 2003;23:519-26.
19. Benarroch EE. New findings on the neuropathology of multiple system atrophy. Auton Neurosci 2002;96:59-62.
20. Stefanova N, Bücke P, Duerr S, et al. Multiple system atrophy: an update. Lancet Neurol 2009;8:1172-8.
21. Jecmenica-Lukic M, Poewe W, Tolosa E, et al. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11:361-8.
22. Calandra-Buonaura G, Guaraldi P, Sambati L, et al. Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? Neurol Sci 2013;34:1875-8.
23. Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J 2010;31:85-91.
24. Wenning GK, Granata R, Krismer F, et al. Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study. Cerebellum 2012;11:223-6.
25. Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin 2002;20:291-301.
26. Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 2003;42:136-42.
27. Shannon J, Jordan J, Costa F, et al. The hypertension of autonomic failure and its treatment. Hypertension 1997;30:1062-7.
28. Flabeau O, Meissner W, Tison F. Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord 2010;3:249-63.
29. Senard JM, Brefel-Courbon C, Rascol O, et al. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging 2001;18:495-505.
30. Asahina M, Vichayanrat E, Low DA, et al. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry 2013;84:674-80.
31. Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 2014;83:328-35.
32. Kaufmann H. L-dihydroxyphenylserine (droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auton Res 2008;18(Suppl 1):19-24.
33. Low PA, Gilden JL, Freeman R, et al. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997;277:1046-51.
34. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998;51:120-4.